Amgen submits new data to challenge FDA's proposal to withdraw Tavneos - Reuters

Amgen submits new data to challenge FDA's proposal to withdraw Tavneos Reuters

1 reportinternational

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage